These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7888 related articles for article (PubMed ID: 21302089)

  • 1. Xenoantisera to human DR antigens: Serological and immunochemical characterization.
    Ferrone S; Naeim F; Indiveri F; Walker LE; Pellegrino MA
    Immunogenetics; 1978 Dec; 7(1):349-58. PubMed ID: 21302089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
    Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
    Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenoantisera to allotypic specificities of HLA-A and B antigens. Serological characterization.
    Richiardi P; Pellegrino MA; Ferrone S
    Transplantation; 1979 Oct; 28(4):333-8. PubMed ID: 92080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of human B cell antigens solubilized from cultured human lymphoid cells.
    Ferrone S; Pellegrino MA; Reisfeld RA
    J Immunol; 1977 Mar; 118(3):1036-41. PubMed ID: 139444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic and immunochemical characterization of HLA-A9 xenoantisera.
    Allison JP; Belvedere M; Reisfeld RA; Pellegrino MA; Ferrone S
    J Immunol; 1978 Aug; 121(2):579-85. PubMed ID: 681750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of anti-W24 xenoantisera in rabbits.
    Ferrone S; Pellegrino MA; Billing R; Terasaki PI; Reisfeld RA
    Tissue Antigens; 1975 Feb; 5(1):41-7. PubMed ID: 1138440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    J Exp Med; 1979 Mar; 149(3):658-68. PubMed ID: 429961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical analysis of anti-HLA-A2, HLA-A3, and HLA-B27 xenoantisera elicited with hybrids between human and murine cells.
    Pellegrino MA; Ng AK; Russo C; Glassy M; Ferrone S
    Immunogenetics; 1981; 14(1-2):141-52. PubMed ID: 7035347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of DR xenoantisera: use for detection of serum DR antigens.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    J Immunol; 1979 May; 122(5):1967-71. PubMed ID: 376728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies in inbred rats. VIII. The production of xenoantisera against Ag-B histocompatibility antigens.
    Edwards PA; Kunz HW; Gill TJ
    J Immunogenet; 1977 Feb; 4(1):53-60. PubMed ID: 856916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of HLA antigens purified from serum.
    Ferrone S; Mittal KK; Pellegrino MA; Allison JP; Reisfeld RA
    Transplantation; 1977 Jan; 23(1):7-15. PubMed ID: 65035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenoantisera to DRw allospecificities.
    Belvedere M; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Apr; 7(2):167-72. PubMed ID: 6155413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.
    Wilson BS; Kay NE; Imai K; Ferrone S
    Cancer Immunol Immunother; 1982; 13(1):69-74. PubMed ID: 7159874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of human leukemia by membrane antigen analysis with xenoantisera.
    Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
    Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of DR antigens on human T lymphoid cells: serologic and immunochemical studies with xenoantisera.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Mar; 11(1):712-4. PubMed ID: 377706
    [No Abstract]   [Full Text] [Related]  

  • 16. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
    Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens.
    McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of immune phagocytosis by human sera with HLA A, B, C and DR but not with DQ or EM type reactivity.
    Neppert J; Pohl E; Mueller-Eckhardt C
    Vox Sang; 1986; 51(2):122-6. PubMed ID: 2430362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes.
    Schirrmacher V; Marxen I; Robinson P
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):155-68. PubMed ID: 85374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 395.